Circulating Plasma Syncytin-1 mRNA in Preeclampsia-A Pilot Study

Area of Science:

• Reproductive biology
• Maternal-fetal medicine
• Molecular diagnostics

Background:

• Syncytin-1, an endogenous retroviral protein, is crucial for placental development and integrity.
• Reduced syncytin-1 expression is linked to preeclampsia (PE), a serious pregnancy complication.
• Investigating circulating fetal syncytin-1 mRNA offers a potential non-invasive method to assess placental health.

Purpose of the Study:

• To examine the role of circulating fetal syncytin-1 mRNA in maternal plasma.
• To compare syncytin-1 mRNA levels in women with and without preeclampsia.
• To evaluate the diagnostic and predictive potential of fetal syncytin-1 mRNA for preeclampsia.

Main Methods:

• A prospective pilot study involving 26 women without PE and 43 women with PE.
• Quantitative real-time PCR was used to measure syncytin-1 mRNA concentrations in maternal plasma.
• Receiver operating curve (ROC) analysis was performed to assess diagnostic accuracy.

Main Results:

• Median circulating syncytin-1 mRNA concentrations were significantly lower in women with PE compared to those without (p < 0.001).
• The area under the ROC curve (AUC) for diagnosing PE at delivery was 0.913.
• Sub-analysis showed high diagnostic (AUC 0.962) and predictive (AUC 0.924) accuracy for fetal syncytin-1 expression.

Conclusions:

• Quantification of fetal syncytin-1 mRNA in maternal plasma shows promise as a diagnostic tool for preeclampsia.
• Circulating fetal syncytin-1 mRNA may also serve as a predictive marker for developing preeclampsia.
• This non-invasive approach could aid in early detection and management of preeclampsia.